Tiziana Life Sciences (TLSA) announced that its Chief Executive Officer, Ivor Elrifi, has purchased 14,848 shares of Tiziana common stock at a price of $1.65 per share in the open market, correcting today’s earlier press release. This brings his current purchased shares total to 193,848, the company stated.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences CEO Buys Shares, Signaling Confidence in Innovative Therapies
- Tiziana Life Sciences announces purchase of shares by CEO
- Tiziana Life Sciences Chairman Increases Stake with Recent Share Purchase
- Tiziana Life Sciences announces purchase of shares by chairman
- Tiziana Life Sciences Initiates Phase 2a Trial for MSA with Intranasal Foralumab